Opinion: Independent third-party entities as a model for validation of commercial antibodies
- Carl Laflamme
- , Aled M. Edwards
- , Anita E. Bandrowski
- , Peter S. McPherson
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.